Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Argenx To Discontinue Phase 3 UNITY Study Of Efgartigimod In Sjgren′s Disease (AFX) +++ ARGENX Aktie -9,09%

WUXI APPTEC Aktie

 >WUXI APPTEC Aktienkurs 
23.69 EUR    -6.4%    (TradegateBSX)
Ask: 23.965 EUR / 500 Stück
Bid: 23.71 EUR / 500 Stück
Tagesumsatz: 649 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
WUXI APPTEC Aktie über LYNX handeln
>WUXI APPTEC Performance
1 Woche: +5,3%
1 Monat: +21,7%
3 Monate: +53,9%
6 Monate: +83,7%
1 Jahr: +93,2%
laufendes Jahr: +138,4%
>WUXI APPTEC Aktie
Name:  WUXI APPTEC H 02359 YC1
Land:  China
Sektor:  Gesundheit
ISIN/ Wkn:  CNE100003F19 / A2PAJG
Symbol/ Ticker:  WX8 (Frankfurt)
Kürzel:  FRA:WX8, ETR:WX8, WX8:GR
Index:  -
Profil:  WuXi AppTec Co., Ltd. is a leading global pharmaceutical and biotechnology company that provides comprehensive research and development services. Its primary function is to facilitate drug discovery and development processes for pharmaceutical compan..
>Volltext..
Marktkapitalisierung:  66812.56 Mio. EUR
Unternehmenswert:  62830.38 Mio. EUR
Umsatz:  6587.63 Mio. EUR
EBITDA:  -
Nettogewinn:  2782.21 Mio. EUR
Gewinn je Aktie:  0.96 EUR
Schulden:  1977.75 Mio. EUR
Liquide Mittel:  3530.62 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  1.62
Umsatzwachstum:  34.13%
Gewinnwachstum:  75.53%
Dividende je Aktie:  0.26 EUR
Dividendenrendite:  1.13%
Dividendenschätzung:  1.11%
Div. Historie:  18.08.26 - 0.06483711€
13.05.26 - 0.1964331€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  WUXI APPTEC
Letzte Datenerhebung:  08.10.26
>WUXI APPTEC Kennzahlen
Aktien/ Unternehmen:
Aktien: 514.66 Mio. St.
Frei handelbar: 95.34%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 33834
Umsatz/Mitarb.: 0.16 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: -0.7%
Bewertung:
KGV: 26.97
KGV lG: 24.64
KUV: -
KBV: -
PEG-Ratio: 0.38
EV/EBITDA: -
Rentabilität:
Bruttomarge: 54.47%
Gewinnmarge: 42.23%
Operative Marge: 42.02%
Managementeffizenz:
Gesamtkaprendite: 21.72%
Eigenkaprendite: 30.34%
>WUXI APPTEC Peer Group
Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten
 
08.10.26 - 02:03
WuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability (PR Newswire)
 
SHANGHAI, Oct. 7, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received a Gold medal from EcoVadis for the third consecutive year, reflecting the Company's consistent commitment to......
06.10.26 - 10:30
Full-day Takeaway: HSI Closes at 24,280, Up 240 pts; HSTI Closes at 4,223, Up 39 pts; J&T EXPRESS-W Up over 5%; WUXI BIO, WUXI APPTEC, GENSCRIPT BIO Hit New Highs (AAStocks)
 
At close, HSI rose 240 pts or 1.0% to 24,280. HSTI rose 39 pts or 0.9% to 4,223. HSCEI gained 77 pts or 1.0% to 8,128. Market turnover reached $98.26 billion.Active Heavyweights:BABA (09988.HK) closed at $108.2, up 2.7%XIAOMI (01810.HK) closed at $24.26, up 1.6%CCB (00939.HK) closed at $9.65, up 1.5%TENCENT (00700.HK) closed at ......
02.10.26 - 05:00
WUXI APPTEC: AI Drug R&D Still In Exploration Stage; CXO Empowerment Needed to Build Industry Closed Loop (AAStocks)
 
Regarding recent reports in both China and the US about collaborations between pharmaceutical companies and well-known AI companies in drug R&D, WUXI APPTEC (02359.HK) stated on an interactive platform that AI in the innovative drug R&D field is still at the exploration and experimentation stage. Down the road, AI is ant......
30.09.26 - 06:30
Research: G Sachs Ratings, TPs on Pharma and Biotech Stocks (Table) (AAStocks)
 
Goldman Sachs issued a research report listing the investment ratings and target prices for pharmaceutical and biotechnology stocks as follows:Stock | Investment Rating | TP WUXI APPTEC (02359.HK) | Buy | HKD220.1WUXI XDC (02268.HK) | Buy | HKD97.9ASYMCHEM (06821.HK) | Buy | HKD168.2PHARMARON (03759.HK) | Buy | HKD37.2TIGERMED (......
11.09.26 - 12:00
Research: G Sachs: China CRO/CDMO Industry Recovery Pace Clear; Positive on WUXI Series, PHARMARON, ASYMCHEM, TIGERMED and GENSCRIPT BIO (AAStocks)
 
G Sachs published a research report stating that results for 2Q26 and 1H26 reflected a clear recovery in China's CRO/CDMO industry, with corporate earnings beating expectations, guidance raised and strong order momentum. It assigned Buy ratings to WUXI APPTEC (02359.HK), WUXI XDC (02268.HK), ASYMCHEM (06821.HK) and PHARMARON (03......
09.09.26 - 09:15
Research: HSBC Research: Healthcare Sector Supported by Resilient Demand, Favors INNOVENT BIO , SKB BIO , WUXI APPTEC (AAStocks)
 
HSBC Global Investment Research published a research report stating that it recently communicated with management teams of 18 healthcare companies during investor events and believes the sector is currently supported by resilient demand. Since Jul 1, healthcare stocks have Outperformed the broader market, with the H-share health......
03.09.26 - 07:30
Research: CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc , WUXI APPTEC (AAStocks)
 
CLSA released a global healthcare sector outlook report stating that the global pharmaceutical supply chain is entering a decade-long restructuring phase. More than USD500 billion of branded drug sales are facing a patent cliff, while broader drug demand and accelerating localization of manufacturing are driving a new wave of R&......
31.08.26 - 08:42
WuXi AppTec announces RMB 1.51B interim cash dividend for 2026 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.08.26 - 02:03
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion (PR Newswire)
 
SHANGHAI, Aug. 30, 2026 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cash dividend. Building on its inaugural......
30.08.26 - 13:30
WUXI APPTEC to Early Redeem Convertible Bonds Due 2027 with Principal of RMB4.973 Billion (AAStocks)
 
WUXI APPTEC (02359.HK) announced the early redemption of USD-settled zero-coupon convertible bonds due 2027 with an aggregate principal amount of RMB6.78 billion. To date, the outstanding principal amount of the bonds was RMB4.973 billion, with the redemption date set for September 27. (de/d)~AASTOCKS Financial NewsWebsite: www.......
30.08.26 - 11:48
CXMT joins growing list of Chinese tech firms suing US Pentagon over blacklists (SCMP)
 
Leading chipmaker ChangXin Memory Technologies (CXMT) has joined a growing list of Chinese technology companies suing the US government over their additions to Pentagon blacklists, as legal experts said US courts had shown a willingness to hold the Department of Defence to account. Recent rulings involving Chinese tech firms including lidar sensor maker Hesai Group, drone manufacturer DJI and biotech firm WuXi AppTec indicated that judges were prepared to scrutinise the US government's evidence......
27.08.26 - 19:30
WUXI APPTEC Sells 4.23% Stake in WUXI XDC, Cashes In HKD3.9B (AAStocks)
 
WUXI APPTEC (02359.HK) announced that on Aug 26, it sold a 4.23% stake in WUXI XDC (02268.HK) through block trades, involving 53.524 million shares with transaction value of HKD3.92 billion. The price per share was approximately HKD73.24. The cash proceeds will be used to continue focusing on its core business and accelerate the......
27.08.26 - 04:00
WUXI APPTEC Reportedly Sells 2.6% Stake in WUXI XDC for Up to HKD2.4B (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
24.08.26 - 21:00
WUXI APPTEC Biology Business DEL Platform Experiences Cybersecurity Incident (AAStocks)
 
WUXI APPTEC (02359.HK) announced that its biology business segment recently experienced a cybersecurity incident, in which certain data on its DNA Encoded Library (DEL) platform was subject to unauthorized access. The DEL platform is a professional encoded chemical synthesis library used for early-stage discovery projects.The co......
21.08.26 - 07:24
WuXi AppTec Becomes Top Short Target as 80% Rally Draws Skeptics (Bloomberg)
 
Chinese biotech firm WuXi AppTec Co. has been one of the market's hottest stocks this year, but its rally is starting to attract a growing group of skeptics....
20.08.26 - 06:30
Midday Takeaway: HSI Up 291 pts; HSTI Up 72 pts; XIAOMI Up over 3%; WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, TINGYI Hit New Highs (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
17.08.26 - 12:06
China′s pharma contractors rally as US supply chain pressures face industry resistance (SCMP)
 
China's pharmaceutical contractors are showing financial resilience in the face of Washington's push to curb reliance on Chinese supply chains. Analysts said investors were bullish because the US government's recent measures to curb Beijing's rise as a global pharmaceutical supplier had met resistance from industry players reluctant to give up China's cost advantages. Hong Kong-listed shares of WuXi AppTec, Asia's largest provider of contract pharmaceutical research, gained 3 per cent on Monday......
17.08.26 - 07:00
H Shrs: HSI Mounts 405 pts at Midday as JD-SW Rebounds 3%+; SMIC Surges 7%+; WUXI APPTEC Sets New High (AAStocks)
 
The HSI opened up 186 pts this morning (17th), with upswing becoming wilder afterward. At midday, the index concluded at 25,521, up 405 pts or 1.61%, with market turnover at HKD118.227 billion; the HSCEI ended at 8,470, up 129 pts or 1.55%; and the HSTECH settled at 4,802, up 94 pts or 2.01%.Major techs broadly advanced. TENCENT......
17.08.26 - 06:30
Midday Takeaway: HSI Up 405 pts; HSTI Up 94 pts; SMIC Up over 7%; WUXI APPTEC, ABLE DIGITAL, SITC Hit New Highs (AAStocks)
 
Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Meine Frau will ich lieber nicht zum Manne nehmen. - Uxori nubere nolo meae. - Marcus Valerius Martial
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!